Elisabetta Treggiari

21PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersChemotherapyTumour immunologySolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Nov 13, 2025
Reply to In response to "Factors associated with the development of gastrointestinal adverse events in dogs with multicentric lymphoma treated with CHOP or CEOP-based protocols: a multi-institutional, retrospective study".

E Treggiari, V Tranquillo, P Valenti

|Sep 25, 2025
Clinical Response to Imatinib Mesylate and Toxicity Profile in 35 Dogs With Mast Cell Tumours.

Elisabetta Treggiari, Emanuela Catania, Paola Valenti

|May 04, 2025
Factors associated with the development of gastrointestinal adverse events in dogs with multicentric lymphoma treated with CHOP or CEOP-based protocols: a multi-institutional, retrospective study.

E Treggiari, E Catania, P Valenti

|Apr 26, 2025
Evaluation of lung lobectomy and adjuvant treatment for primary pulmonary carcinoma in dogs: 89 cases (2005-2022).

E Treggiari, G Romanelli, P Valenti

|Oct 18, 2024
Comparison of CHOP-19 and CHOP-25 for treatment of peripheral nodal B-cell lymphoma in dogs: A European multicenter retrospective cohort study.

Charles Hawkes, Joanna Morris, Spela Bavcar

|Jun 19, 2024
Use of Lomustine and Prednisolone as First-Line Treatment in Canine Multicentric Lymphoma.

Chiara Catalucci, Marco Luigi Bianchi, Elisabetta Treggiari

Pageof 4

Frequent Collaborators

3 joint publications

Angela Taylor

2 joint publications

Silvia Ferro

2 joint publications

Ilaria Porcellato

1 joint publications

J W Elliott